[Back To Home] [Back To Archives] From Intellectual Property Law Daily , June 18, 2015 By Mark Engstrom, J.D. Patent claims describing the molecular weight of the active ingredient of the multiple sclerosis drug Copaxone were invalid for ... Wolters Kluwer Law & Business, 1 week ago
P R ES S RE L EAS E FOR IMMEDIATE RELEASE Gemological Science International to Offer Sarine Profile TM with Diamond Grading Reports Kfar Saba, 21 June 2015 - Singapore Exchange Mainboard-listed Sarine Technologies Ltd ("Sarine") (U77:SI), a ...4 Traders, 1 week ago
MOMENTA PHARMACEUTICALS INC - 10-Q - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion of our financial condition and results of operations should be read in conjunction with our condensed consolidated financial statements and notes thereto appearing elsewhere in this Quarterly Report on Form 10-Q and the ...Pharmacy Choice, 1 month ago
on your WebpageAdd Widget >Get your members hooked!